Evoke Pharma, Inc. (EVOK)
Dec 17, 2025 - EVOK was delisted (reason: acquired by QOL Medical)
11.00
+0.04 (0.36%)
Inactive · Last trade price on Dec 16, 2025

Evoke Pharma Revenue

Evoke Pharma had revenue of $4.28M in the quarter ending September 30, 2025, with 61.40% growth. This brings the company's revenue in the last twelve months to $14.42M, up 67.40% year-over-year. In the year 2024, Evoke Pharma had annual revenue of $10.25M with 97.84% growth.

Revenue (ttm)
$14.42M
Revenue Growth
+67.40%
P/S Ratio
2.12
Revenue / Employee
$4,808,217
Employees
3
Market Cap
23.72M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202410.25M5.07M97.84%
Dec 31, 20235.18M2.67M106.51%
Dec 31, 20222.51M890.57K55.04%
Dec 31, 20211.62M1.60M6,929.00%
Dec 31, 202023.02K--
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro